captopril has been researched along with Renal Insufficiency, Chronic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, T; Alqahtani, F; Alqahtani, NS; Alshammari, FA; Imran, I; Khalid, S; Masood, I; Rasool, MF; Saeed, H | 1 |
| Bovée, DM; Clahsen-van Groningen, MC; Danser, AHJ; Domenig, O; Foster, D; Garrelds, IM; Hoorn, EJ; Huang, S; Kim, JB; Lu, X; Melton, L; Poglitsch, M; Ren, L; Uijl, E; van Veghel, R; Zlatev, I | 1 |
| Alali, AS; AlAsmari, AF; Alasmari, F; Ali, M; Ali, N; Ali, S; Alqahtani, F; Asiri, AM; Imran, I; Khalid, R; Khalid, S; Majeed, A; Rasool, MF; Saeed, H; Usman, M | 1 |
| Arellano-Mendoza, MG; Del Valle-Mondragón, L; Guevara-Salazar, JA; Montes-Rivera, JO; Quintana-Pérez, JC; Tamay-Cach, F; Trujillo-Ferrara, JG | 1 |
| Bastacky, SI; Jackson, EK; Salah, EM; Tofovic, SP | 1 |
| Fukushima, N; Horiba, N; Maeda, A; Miyamoto, KI; Segawa, H | 1 |
| Adamcová, M; Arendášová, K; Aziriová, S; Bárta, A; Celec, P; Hrenák, J; Kamodyová, N; Krajčírovičová, K; Paulis, L; Rajkovičová, R; Repová, K; Simko, F | 1 |
| Lerman, LO | 1 |
| Blankestijn, PJ; Hoogduin, H; Leiner, T; Mali, WP; Siddiqi, L; Visser, F | 1 |
9 other study(ies) available for captopril and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease.
Topics: Adult; Captopril; Child; Computer Simulation; Humans; Hypertension; Models, Biological; Prednisone; Renal Insufficiency, Chronic | 2023 |
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease.
Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Arterial Pressure; Captopril; Disease Models, Animal; Kidney; Liver; Losartan; Rats; Renal Insufficiency, Chronic; Renin-Angiotensin System; RNA, Small Interfering | 2021 |
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Captopril; Chronic Disease; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Models, Biological; Pharmacokinetics; Renal Insufficiency, Chronic; Reproducibility of Results; Young Adult | 2021 |
Apocynin combined with drugs as coadjuvant could be employed to prevent and/or treat the chronic kidney disease.
Topics: Acetophenones; Adjuvants, Pharmaceutic; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Captopril; Disease Models, Animal; Disease Progression; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Humans; Losartan; Mice; Mice, Inbred C57BL; Oxidative Stress; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Comorbidity; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Kidney; Male; Metabolic Syndrome; Rats, Zucker; Renal Circulation; Renal Insufficiency, Chronic; Renin-Angiotensin System; Stroke Volume; Ventricular Function, Left; Ventricular Pressure | 2018 |
The Role of Extracellular Phosphate Levels on Kidney Disease Progression in a Podocyte Injury Mouse Model.
Topics: Animals; Calcium; Captopril; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Kidney Tubules; Klotho Proteins; Male; Mice; Parathyroid Hormone; Phosphates; Podocytes; Renal Insufficiency, Chronic; RNA, Messenger; Sevelamer | 2019 |
Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Doxorubicin; Glomerular Filtration Rate; Imidazoles; Male; Melatonin; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 2; Renal Agents; Renal Insufficiency, Chronic; Tetrazoles; Treatment Outcome | 2013 |
Imaging: BOLD assessment--effects of RAAS inhibition in CKD.
Topics: Amides; Captopril; Female; Fumarates; Humans; Kidney; Magnetic Resonance Imaging; Male; Oxygen; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2014 |
Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease.
Topics: Adult; Aged; Amides; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Case-Control Studies; Comorbidity; Feasibility Studies; Female; Fumarates; Humans; Hypertension; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Pilot Projects; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Treatment Outcome | 2014 |